The Enterprise Value as of September 2024 (TTM) for 89bio, Inc. (ETNB) is 712.19M

According to 89bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 712.19M. This represents a change of -4.78% compared to the average of 747.97M of the last 4 quarters.

89bio, Inc. (ETNB) Historical Enterprise Value (quarterly & annually)

How has ETNB Enterprise Value performed in the past?

The mean historical Enterprise Value of 89bio, Inc. over the last ten years is 218.28M. The current 712.19M Enterprise Value has changed 32.53% with respect to the historical average. Over the past ten years (40 quarters), ETNB's Enterprise Value was at its highest in in the June 2023 quarter at 1.18B. The Enterprise Value was at its lowest in in the September 2018 quarter at 0.

89bio, Inc. (ETNB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of 89bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

89bio, Inc. (ETNB) Average Enterprise Value

How has ETNB Enterprise Value performed in the past?

The current Enterprise Value of 89bio, Inc. (ETNB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

89bio, Inc. (ETNB) Enterprise Value vs. Peers

How is ETNB’s Enterprise Value compared to its peers?

89bio, Inc.’s Enterprise Value is less than Madrigal Pharmaceuticals, Inc. (4.91B), less than Pliant Therapeutics, Inc. (762.35M), less than Arcellx, Inc. (3.80B), greater than Stoke Therapeutics, Inc. (586.20M), less than Day One Biopharmaceuticals, Inc. (1.01B), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Inozyme Pharma, Inc. (343.89M), greater than Acumen Pharmaceuticals, Inc. (93.64M), greater than Mereo BioPharma Group plc (582.99M), less than Viking Therapeutics, Inc. (5.95B), less than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (458.36M), less than Akero Therapeutics, Inc. (1.56B), less than Reata Pharmaceuticals, Inc. (6.68B), greater than HOOKIPA Pharma Inc. (87.25M), less than TG Therapeutics, Inc. (3.44B), greater than Hepion Pharmaceuticals, Inc. (2.24M),

Build a custom stock screener for 89bio, Inc. (ETNB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 89bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

89bio, Inc. (ETNB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like 89bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.